Anti-CD3×anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets
Pediatric Blood & Cancer, 06/22/2012
Yankelevich M et al. – These preclinical findings support the potential of a novel immunotherapeutic approach to target T cells to neuroblastoma.



